Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 85
Filter
1.
NPJ Digit Med ; 4(1): 138, 2021 Sep 17.
Article in English | MEDLINE | ID: mdl-34535755

ABSTRACT

People with diabetes (PWD) have an increased risk of developing influenza-related complications, including pneumonia, abnormal glycemic events, and hospitalization. Annual influenza vaccination is recommended for PWD, but vaccination rates are suboptimal. The study aimed to increase influenza vaccination rate in people with self-reported diabetes. This study was a prospective, 1:1 randomized controlled trial of a 6-month Digital Diabetes Intervention in U.S. adults with diabetes. The intervention group received monthly messages through an online health platform. The control group received no intervention. Difference in self-reported vaccination rates was tested using multivariable logistic regression controlling for demographics and comorbidities. The study was registered at clinicaltrials.gov: NCT03870997. A total of 10,429 participants reported influenza vaccination status (5158 intervention, mean age (±SD) = 46.8 (11.1), 78.5% female; 5271 control, Mean age (±SD) = 46.7 (11.2), 79.4% female). After a 6-month intervention, 64.2% of the intervention arm reported influenza vaccination, vers us 61.1% in the control arm (diff = 3.1, RR = 1.05, 95% CI [1.02, 1.08], p = 0.0013, number needed to treat = 33 to obtain 1 additional vaccination). Completion of one or more intervention messages was associated with up to an 8% increase in vaccination rate (OR 1.27, 95% CI [1.17, 1.38], p < 0.0001). The intervention improved influenza vaccination rates in PWD, suggesting that leveraging new technology to deliver knowledge and information can improve influenza vaccination rates in high-risk populations to reduce public health burden of influenza. Rapid cycle innovation could maximize the effects of these digital interventions in the future with other populations and vaccines.

2.
Klin Onkol ; 34(2): 153-162, 2021.
Article in English | MEDLINE | ID: mdl-33906365

ABSTRACT

BACKGROUND: Oral cavity injuries are very significant complications in the treatment of oncological and hemato-oncological patients. Preventive and curative interventions and patient education reduce the risk of complications and their consequences. A working group of authors from professional groups prepared recommendations for care. PURPOSE: A basic summary of recommended interventions to prevent and treat oral cavity injuries in daily practice, defined on the basis of expert societies guidelines, trials, literature data and proven practice and on the consensus opinions of the authors group members. RESULTS: Preventive measures and patient education are essential in the approach to dealing with oral injuries in chemotherapy, radiotherapy, risky targeted treatment and osteonecrosis of the jaw. Local care products are an important element of care, in case of infections, their antimicrobial action is essential, in case of graft-versus-host disease or in connection with targeted oncological therapy, corticoids are used. CONCLUSION: The recommended procedures contribute to the reduction of the development, severity and consequences of oral complications in oncological and hemato-oncological patients.


Subject(s)
Mouth Diseases/therapy , Neoplasms/therapy , Humans , Mouth Diseases/etiology , Patient Education as Topic
3.
J Thromb Haemost ; 10(4): 557-63, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22329762

ABSTRACT

BACKGROUND: During and shortly after coronary artery bypass graft (CABG) surgery, there is an increase in thromboembolic events. CABG, a strong inflammatory stimulus, is associated with a hypercoaguable state. Platelets might contribute to this hypercoaguable state because they have a pivotal role in thrombosis. In the days following surgery there is augmented platelet regeneration in response to the inflammatory stimulus. OBJECTIVES: The aim of this study was to investigate any changes in platelet mRNA profiles to test the hypothesis that post-CABG surgery platelets are associated with a prothrombotic state. METHODS: Blood was sampled and platelets purified from 11 patients before and 3-6 days after CABG. Gene expression profiling was performed using low density array (LDA) plates for seven of the patients. RESULTS: Forty-five genes were examined and those significantly up-regulated were glycoprotein (GP)IIb, GPIIIa and cyclooxygenase-1 (COX-1). These findings were confirmed in four more patients, including flow cytometry analysis of the GPIIb/IIIa receptor. CONCLUSIONS: CABG surgery up-regulates mRNA and protein levels of proteins that are key players in platelet aggregation. Marked elevation of GPIIb/IIIa mRNA levels results in significantly increased GPIIb/IIIa expression in platelets post-CABG surgery, which may be a reason for increased thrombus formation and myocardial infarction after CABG.


Subject(s)
Blood Platelets/metabolism , Coronary Artery Bypass/adverse effects , Platelet Aggregation/genetics , Thrombosis/genetics , Aged , Aged, 80 and over , Cyclooxygenase 1/genetics , Female , Flow Cytometry , Gene Expression Profiling , Humans , Integrin alpha2/genetics , Integrin beta3/genetics , Male , Middle Aged , Myocardial Infarction/blood , Myocardial Infarction/etiology , Myocardial Infarction/genetics , Platelet Endothelial Cell Adhesion Molecule-1/genetics , Platelet Glycoprotein GPIIb-IIIa Complex/genetics , Platelet Glycoprotein GPIIb-IIIa Complex/metabolism , RNA, Messenger/blood , Risk Assessment , Risk Factors , Sweden , Thrombosis/blood , Thrombosis/etiology , Time Factors , Treatment Outcome , Up-Regulation
4.
Endocr Regul ; 46(1): 21-6, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22329818

ABSTRACT

OBJECTIVE: The proposed therapeutical effect of phytol (PHY), a precursor of the phytanic acid (PHYA), on mammary tumours induced with 1-methyl-1-nitrosourea (MNU), was investigated in Sprague-Dawley rats in combination with vitamin D analogue, Seocalcitol (SEO). METHODS: Female Sprague-Dawley rats were administered intraperitoneally with MNU (50 mg/kg of body weight) at the 46th and 52th days of age. Controls and MNU animals received propyleneglycol appropriate to their body weight. PHY (MNU + PHY) (500 mg/kg) was administered after tumour detection (approximately in 100th day of the life) three times/week. Combination of PHY with SEO (7 µg/kg per week) was administered to rats after tumour detection (approximately in 100th day of the life) until the 181st day of age. Then the animals were sacrificed, the tumours removed, and fixed in 10% formalin. Haematoxylin and eosine stained sections were evaluated under microscope. RESULTS: Tumour invasiveness observed in all groups of animals was ranging from 80 to 90%. Treatment with PHY alone did not inhibit the progression of the MNU induced tumours in the rat breast but it decreased the tumour burden and volume in comparison with MNU treated controls. Decreased tumour burden and volume were induced by combined treatment of PHY with SEO. Malignity and invasivity of carcinomas were not affected. CONCLUSION: No redifferentiating effect on mammary tumour cells induced by NMU after treatment with PHY alone or in combination with SEO was observed in rats. SEO alone or in combination with PHY inhibited the progression of MNU induced mammary tumours and also inhibited the increase of tumour burden and volume in comparison with MNU treated control group. However, none of the compounds, either alone or in mutual combination, reduced the malignity or the number of invasive tumours in this experimental study.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma/drug therapy , Carcinoma/pathology , Mammary Neoplasms, Experimental/drug therapy , Mammary Neoplasms, Experimental/pathology , Alkylating Agents , Animals , Carcinoma/chemically induced , Disease Progression , Drug Evaluation, Preclinical , Female , Mammary Neoplasms, Experimental/chemically induced , Methylnitrosourea , Phytanic Acid/administration & dosage , Phytanic Acid/analogs & derivatives , Phytanic Acid/chemistry , Rats , Rats, Sprague-Dawley , Tumor Burden/drug effects , Vitamin D/administration & dosage , Vitamin D/analogs & derivatives
5.
J Appl Toxicol ; 31(2): 95-107, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21321970

ABSTRACT

Arsenic (As) is a toxic metalloid element that is present in air, water and soil. Inorganic arsenic tends to be more toxic than organic arsenic. Examples of methylated organic arsenicals include monomethylarsonic acid [MMA(V)] and dimethylarsinic acid [DMA(V)]. Reactive oxygen species (ROS)-mediated oxidative damage is a common denominator in arsenic pathogenesis. In addition, arsenic induces morphological changes in the integrity of mitochondria. Cascade mechanisms of free radical formation derived from the superoxide radical, combined with glutathione-depleting agents, increase the sensitivity of cells to arsenic toxicity. When both humans and animals are exposed to arsenic, they experience an increased formation of ROS/RNS, including peroxyl radicals (ROO•), the superoxide radical, singlet oxygen, hydroxyl radical (OH•) via the Fenton reaction, hydrogen peroxide, the dimethylarsenic radical, the dimethylarsenic peroxyl radical and/or oxidant-induced DNA damage. Arsenic induces the formation of oxidized lipids which in turn generate several bioactive molecules (ROS, peroxides and isoprostanes), of which aldehydes [malondialdehyde (MDA) and 4-hydroxy-nonenal (HNE)] are the major end products. This review discusses aspects of chronic and acute exposures of arsenic in the etiology of cancer, cardiovascular disease (hypertension and atherosclerosis), neurological disorders, gastrointestinal disturbances, liver disease and renal disease, reproductive health effects, dermal changes and other health disorders. The role of antioxidant defence systems against arsenic toxicity is also discussed. Consideration is given to the role of vitamin C (ascorbic acid), vitamin E (α-tocopherol), curcumin, glutathione and antioxidant enzymes such as superoxide dismutase, catalase and glutathione peroxidase in their protective roles against arsenic-induced oxidative stress.


Subject(s)
Arsenic Poisoning , Arsenic/toxicity , Environmental Pollutants/toxicity , Oxidative Stress , Poisons/toxicity , Animals , Arsenic/administration & dosage , Arsenic Poisoning/physiopathology , Arsenicals/administration & dosage , Biomarkers/blood , Biomarkers/metabolism , Biomarkers/urine , Cardiovascular Diseases/chemically induced , Environmental Pollutants/administration & dosage , Humans , Mutagens/administration & dosage , Mutagens/toxicity , Neoplasms/chemically induced , Poisons/administration & dosage , Reactive Nitrogen Species/metabolism , Reactive Oxygen Species/metabolism
7.
Endocr Regul ; 39(3): 73-83, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16468229

ABSTRACT

Classification of thyroid tumours and their variants is described with special respect to some recent findings on somatic mutations characteristics which are associated with individual types of malignity. Special attention is paid to the interrelations between thyroid nodules and malignity and predictive risk factors are listed.


Subject(s)
Thyroid Neoplasms/classification , Thyroid Neoplasms/pathology , Adenocarcinoma, Follicular/genetics , Adenocarcinoma, Follicular/pathology , Adenoma, Oxyphilic/genetics , Adenoma, Oxyphilic/pathology , Carcinoma/genetics , Carcinoma/pathology , Carcinoma, Medullary/genetics , Carcinoma, Medullary/pathology , Carcinoma, Papillary, Follicular/genetics , Carcinoma, Papillary, Follicular/pathology , DNA, Neoplasm/genetics , Female , Humans , Male , Mutation , Thyroid Neoplasms/genetics
8.
Br J Anaesth ; 94(2): 174-80, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15542536

ABSTRACT

BACKGROUND: Pulmonary endothelial dysfunction may occur after ischaemia-reperfusion injury and can be revealed as a reduced vasodilatory response upon administration of acetylcholine (ACh). ACh also releases the endothelium-derived vasodilator nitric oxide but direct measurements of this gas are difficult to perform in vivo. We wanted to study the effects of i.v. administration of ACh and the endothelium-independent vasodilator nitroglycerin on exhaled nitric oxide in relation to pulmonary endothelial dysfunction after open-heart surgery and cardiopulmonary bypass (CPB). METHODS: Basal exhaled nitric oxide and the response in exhaled nitric oxide to i.v. injections of ACh and nitroglycerin were measured with chemiluminescence in 10 patients before and after open-heart surgery. RESULTS: Exhaled nitric oxide decreased significantly after CPB. I.V. bolus injections of ACh induced a reproducible and dose-dependent increase in exhaled nitric oxide that was unaltered after CPB. In contrast, the increase in exhaled nitric oxide evoked by nitroglycerin was attenuated after CPB. The response in pulmonary vascular resistance index (PVRI) to an infusion of ACh decreased after CPB, indicating endothelial dysfunction. The decrease in PVRI response to ACh correlated to the duration of CPB. CONCLUSIONS: Interestingly, pulmonary vascular dysfunction after CPB was accompanied by a reduction in the exhaled nitric oxide response to nitroglycerin and lower levels of basal exhaled nitric oxide. The ACh-induced responses in exhaled nitric oxide were unchanged, which could indicate nitric oxide-independent mechanisms behind the endothelial dysfunction in this study. The possibility of using exhaled nitric oxide dynamics to investigate pulmonary endothelial dysfunction merits further studies.


Subject(s)
Cardiac Surgical Procedures , Cardiopulmonary Bypass , Nitric Oxide/metabolism , Postoperative Complications/metabolism , Reperfusion Injury/metabolism , Acetylcholine/pharmacology , Aged , Aged, 80 and over , Biomarkers/metabolism , Breath Tests/methods , Dose-Response Relationship, Drug , Endothelium, Vascular/drug effects , Endothelium, Vascular/physiopathology , Female , Humans , Male , Middle Aged , Nitroglycerin/pharmacology , Postoperative Complications/physiopathology , Pulmonary Artery/physiopathology , Reperfusion Injury/physiopathology , Vascular Resistance/drug effects , Vasodilator Agents/pharmacology
9.
Cesk Fysiol ; 53(2): 76-9, 2004.
Article in Czech | MEDLINE | ID: mdl-15709642

ABSTRACT

Sport performance is followed by a high production of free radicals. The main reasons are reperfusion after the previous imbalance between the increased need of the organism and the ability of blood supply by oxygen, increased production of ATP, decomposition of the cells particularly white blood cells, oxidation of the purin basis from DNA, stress, output of epinephrine release of free iron, increased temperature in the muscle and its inflammation, and the reception of free radicals from external environment. Peroxidation of lipids, proteins, DNA and other compounds follows the previous biochemical steps. Antioxidants are consumed by free radicals, antioxidative enzymes are released into blood plasma, intracellular calcium is increased, the production of nitric oxide rises, the levels of hydrogen peroxide and hypochlorous acid increase. These penetrate through the membranes and oxidatively damage the tissues. Training improves the ability of the organism to balance the increased load of free radicals. The damage can be lowered by the application of a mixture of antioxidants, the most important are vitamin C, A, E, glutathione, selenium, carnosine, eventually bioflavonoids and ginkgo biloba. The lack of antioxidants can significantly diminish the sport performance and therefore the supplementation with antioxidants is for top sportsmen but also for aged people advisable.


Subject(s)
Antioxidants/metabolism , Free Radicals/metabolism , Physical Exertion/physiology , Sports , Antioxidants/administration & dosage , Humans
10.
Methods Find Exp Clin Pharmacol ; 25(9): 717-21, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14685299

ABSTRACT

The aim of this study was to investigate the effects of the oral administration of stobadine (STB), a neuro- and cardioprotective drug with high antioxidant properties, on selective biochemical variables in pregnant and lactating mice. STB was administered orally at a dose of 50 mg/kg from day 15 of gestation to day 21 of lactation. Creatinine and urea were determined in serum, while acidity, proteins, glucose, ketones, bilirubin, urobilinogen, blood and creatinine were determined in urine from females on days 0, 15 and 18 of gestation and on days 7, 14, 21, and 28 postpartum (pp). In the biochemical variables investigated, no significant differences in STB-treated animals compared with controls were recorded on any of the days studied. Histopathological examination of kidney tissue did not reveal any adverse effect of STB administration.


Subject(s)
Carbolines/administration & dosage , Lactation/drug effects , Lactation/metabolism , Prenatal Exposure Delayed Effects , Administration, Oral , Animals , Female , Kidney/drug effects , Kidney/metabolism , Lactation/blood , Lactation/urine , Mice , Pregnancy
11.
Cardiovasc Surg ; 11(6): 497-505, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14627973

ABSTRACT

Angiographies of 384 patients who had coronary artery bypass surgery because of left main coronary artery (LMCA) obstruction during 1970-1989 were reviewed by analysing the pathology, feasibility of surgical angioplasty and survival. Complete LMCA occlusion was found in 2%, proximal ostial stenosis in 9%, mid-shaft stenosis in 24%, circular stenosis in 25% and distal bifurcation stenosis in 40% of the patients. Patients with an ostial stenosis were younger, more often women with less coronary artery disease and less calcified obstructions. Surgical angioplasty could have been an option in 22% of the patients. Early mortality was higher in patients with (4.7%) than in those without (1.9%) LMCA obstruction. The relative risk (RR) of early death was 1.9 (95% CL 1.1-3.5) after adjustment for patient characteristics. Similarly, the RR at 10 years was 1.3 (95% CL 1.0-1.6). LMCA obstruction was associated with an early and long-term increased mortality after surgery compared to patients without LMCA obstruction.


Subject(s)
Angioplasty/methods , Coronary Artery Bypass/methods , Coronary Stenosis/surgery , Age Factors , Aged , Coronary Angiography , Coronary Stenosis/classification , Coronary Stenosis/diagnostic imaging , Epidemiologic Methods , Female , Humans , Male , Middle Aged , Observer Variation , Treatment Outcome
12.
J Chem Ecol ; 27(6): 1163-76, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11504021

ABSTRACT

Our objective was to test the hypothesis that the pheromone blend and/or diel periodicity of pheromonal communication differ in populations of the nun moth, Lymantria monacha (Lepidoptera: Lymantriidae), from eastern Asia (northern Honshu, Japan) and Central Europe (Bohemia, Czech Republic). Coupled gas chromatographic-electroantennographic detection (GC-EAD) analyses of pheromone gland extract of female L. monacha from Japan confirmed the presence of compounds previously identified in pheromone extracts of L. monacha from Bohemia, as follows: (Z)-7-octadecene, 2-methyl-(Z)-7-octadecene (2me-Z7-18Hy), cis-7,8-epoxy-octadecane (monachalure), and cis-7,8-epoxy-2-methyloctadecane (disparlure). Field experiments in Honshu suggested that (+)-monachalure is the major pheromone component of L. monacha. 2me-Z7-18Hy significantly enhanced attractiveness of (+)-monachalure. Addition of (+)-disparlure to (+)-monachalure plus 2me-Z7-18Hy in Honshu and Bohemia increased attractiveness of lures by 1.2 and 20 times, respectively, indicating that (+)-disparlure is of least and most significance in the respective L. monacha populations. Moreover, capture of male L. monacha in pheromone-baited traps between 18:00 and 24:00 hr in Bohemia and 2:00 and 5:00 hr in Honshu revealed a markedly different diel periodicity of pheromonal communication. Pheromonal communication late at night and use of (+)-monachalure, rather than (+)-disparlure, as the major pheromone component by L. monacha in Honshu may have resulted from interspecific competition with coseasonal L. fumida, which uses the early night for pheromonal communication and (+)-disparlure as major pheromone component. Whether communication channel divergence of L. monacha in Honshu indeed constitutes a case of reproductive character displacement is difficult to prove. The evolution of such divergence in sympatric populations of L. fumida and L. monacha would have to be demonstrated.


Subject(s)
Animal Communication , Moths/physiology , Sex Attractants/pharmacology , Sexual Behavior, Animal/physiology , Animals , Chemotaxis , Chromatography, Gas , Circadian Rhythm , Electrophysiology , Female , Male
13.
Ann Thorac Surg ; 71(5): 1512-7, 2001 May.
Article in English | MEDLINE | ID: mdl-11383792

ABSTRACT

BACKGROUND: Elevated levels of serum S100B after coronary artery bypass grafting may arise from extracerebral contamination. Serum S100B content was analyzed in several tissues, and the two dimers S100A1-B and S100BB were analyzed separately in blood. METHODS: Serum, shed blood, marrow, fat, and muscle were studied in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass using suction either to the cardiotomy reservoir (group 1, n = 10) or to a cell-saving device (group 2, n = 10), or operated on off-pump (group 3, n = 10). RESULTS: Serum S100B was sixfold higher in group 1 than in groups 2 and 3, which were identical. The same ratio between S100A1-B and S100BB was found in all groups. When compared with serum, S100B was 10(2) to 10(4) times higher in marrow, fat, muscle tissue, and shed blood. CONCLUSIONS: Separate analysis of S100A1-B and S100BB did not distinguish between S100B of cerebral and extracerebral origin. The concept that S100B only originates in astroglial and Schwann cells is wrong. Fat, muscle, and marrow in mediastinal blood contain high levels of S100B. Cardiopulmonary bypass caused no increase in S100B.


Subject(s)
Brain/metabolism , Calcium-Binding Proteins/blood , Intraoperative Complications/blood , Nerve Growth Factors/blood , S100 Proteins , Stroke/blood , Adult , Aged , Diagnosis, Differential , Female , Humans , Intraoperative Complications/diagnosis , Male , Middle Aged , Predictive Value of Tests , S100 Calcium Binding Protein beta Subunit , Stroke/diagnosis , Tissue Distribution
14.
Acta Anaesthesiol Scand ; 45(4): 441-8, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11300382

ABSTRACT

BACKGROUND: Acetylcholine is an endothelium-dependent vasodilator through the L-arginine-nitric oxide pathway. After ischemia-reperfusion this effect is attenuated, also demonstrated in the pulmonary circulation after cardiopulmonary bypass. Administration of L-arginine has been shown to have a protective effect on endothelial function in reperfusion injury. The aim of the current study was to test the possible effect of L-arginine on the acetylcholine reactivity in the pulmonary circulation after cardiopulmonary bypass. METHODS: Thirty-five patients with ischemic and/or valvular heart disease were investigated in a randomized, double-blinded, placebo-controlled study. The patients were divided into three groups. Group 1: high dose L-arginine (n=10), group 2: low dose L-arginine (n=10), group 3: placebo, no L-arginine, (n=15). The acetylcholine reactivity was tested with measurements of pulmonary vascular resistance before surgery and 1, 2 and 3-4 h after cardiopulmonary bypass. RESULTS: After cardiopulmonary bypass an attenuation of the acetylcholine reactivity over time was observed in all groups, with no differences between groups. CONCLUSION: In the current study L-arginine had no protective effect on the pulmonary endothelium after cardiopulmonary bypass, measured as reactivity to an infusion of acetylcholine.


Subject(s)
Arginine/therapeutic use , Cardiopulmonary Bypass/adverse effects , Endothelium, Vascular/drug effects , Pulmonary Circulation/drug effects , Acetylcholine/physiology , Adult , Aged , Aged, 80 and over , Arginine/blood , Cardiac Output/drug effects , Double-Blind Method , Female , Hemodynamics/drug effects , Humans , Male , Middle Aged , Stroke Volume/drug effects , Stroke Volume/physiology , Vascular Resistance/drug effects
15.
Ann Thorac Surg ; 71(1): 265-9, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11216759

ABSTRACT

BACKGROUND: The aim of this study was to evaluate the effects of a short period of ischemia (10 mins) and a prolonged period of ischemia (60 mins) followed by reperfusion on coronary flow changes induced by acetylcholine (ACh), adenosine (ADO), and endothelin (ET). METHODS: The left anterior descending coronary artery in anesthetized pigs was occluded for 10 or 60 minutes followed by 120 minutes reperfusion. Thereafter, the flow changes in the left anterior descending coronary artery were studied after intracoronary infusion of ACh, ADO, and ET. RESULTS: Short-term ischemia (10 minutes) caused a decrease in vasodilatation, but not the vasoconstriction response to ACh. Prolonged ischemia (60 minutes) impaired ADO induced vasodilatation and aggravated ET evoked vasoconstriction. CONCLUSIONS: The present findings suggest that a short period of ischemia (10 minutes) causes disturbances of the endothelial regulation of coronary vascular tone and that this endothelial regulation is more sensitive, and precedes changes in vascular smooth muscle function after ischemia and reperfusion.


Subject(s)
Coronary Vessels/physiopathology , Endothelium, Vascular/physiopathology , Ischemia/physiopathology , Animals , Cardiopulmonary Bypass , Female , Male , Muscle, Smooth, Vascular/physiopathology , Myocardial Reperfusion , Random Allocation , Swine , Time Factors , Vasodilation
16.
Gen Physiol Biophys ; 20(3): 293-302, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11765219

ABSTRACT

Type I, iodothyronine 5'-deiodinase (5'-DI) catalyses deiodination of the prohormone thyroxine (T4) to the metabolically active 3,5,3'-triiodo-L-thyronine (T3). The present study was undertaken to investigate the activity of 5'-DI in rat mammary gland tumours representing various combinations of histologically defined papillary, cribriform or comedo patterns of ductal carcinomas. Female Sprague-Dawley rats were given two doses 50 mg x kg(-1) 1-methyl-1-nitrosourea (MNU) in abdominal parts on the 52nd day and 113th day of age. We have found that in comparison with non-lactating mammary gland, the activity of 5'-DI in all mammary gland tumours studied was significantly (p < 0.0001) increased and that the 5'-DI activity, expressed as pmol of 125I- released per min and per mg of protein, in malignant mammary gland tumours was found to be at least two order higher than that of intact mammary non-lactating gland. From our data, we suggest that thyroid hormone in mammary gland tumours might play a significant role to support high energetic expenditure of neoplastic tissues.


Subject(s)
Mammary Neoplasms, Animal/enzymology , Animals , Carcinogens , Carcinoma/enzymology , Female , Iodide Peroxidase/metabolism , Mammary Neoplasms, Animal/pathology , Methylnitrosourea , Rats , Rats, Sprague-Dawley , Time Factors
17.
Gen Physiol Biophys ; 20(4): 445-8, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11989654

ABSTRACT

In the present work the role of 13-cis retinoic acid and CpG oligodeoxynucleotides (CpG-ODN) in a 1-methyl-1-nitrosourea (MNU)-induced mammary gland carcinoma animal model was investigated. Treatment with both components, applied either alone or in combination, induced a significant decrease of the tumour burden and the volume of tumours only in rats that received CpG-ODN (p = 0.046, compared to the MNU control group). The data indicate that the Th-1 biased immunostimulatory capacities of CpG motifs may play a significant role in induction of protective immune responses against mammary gland tumours in Sprague-Dawley rats.


Subject(s)
Carcinogens , CpG Islands , Mammary Neoplasms, Animal/chemically induced , Methylnitrosourea , Neoplasms, Experimental/prevention & control , Alkylating Agents/pharmacology , Amino Acid Motifs , Animals , Female , Models, Statistical , Rats , Rats, Sprague-Dawley , Tretinoin/pharmacology
18.
Endocr Regul ; 34(2): 91-6, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10911410

ABSTRACT

OBJECTIVE: To induce, evaluate and classify advanced stages of mammary gland tumours induced by MNU. METHODS: Female Sprague-Dawley rats were injected intraperitoneally with 1-methyl-1-nitrosourea (MNU; 50 mg.kg-1) on the day 33, 40, 47, 54 and 61 of age in the first experiment and on 50th and 113th day in the second experiment. On the 117th day (first experiment) and on the 153rd day of age (second experiment) the rats were sacrificed by decapitation and their mammary glands were evaluated both macroscopically and microscopically for the presence of grossly detectable mammary tumours. Mammary tumours were classified according to Russo et al. (1990). RESULTS AND CONCLUSIONS: The final incidence of palpable carcinomas was ranging from 60 % to 76 %. All microscopically evaluated tumours were malignant. Among the total number of lesions classified the percentage of invasive tumours ranged from 35 % to 44 %. No metastases were observed in other organs in MNU treated animals.


Subject(s)
Mammary Neoplasms, Experimental/chemically induced , Mammary Neoplasms, Experimental/pathology , Methylnitrosourea , Adenocarcinoma/chemically induced , Adenocarcinoma/pathology , Animals , Carcinoma/chemically induced , Carcinoma/pathology , Carcinoma in Situ/chemically induced , Carcinoma in Situ/pathology , Carcinoma, Ductal, Breast/chemically induced , Carcinoma, Ductal, Breast/pathology , Carcinoma, Papillary/chemically induced , Carcinoma, Papillary/pathology , Female , Mammary Glands, Animal/pathology , Rats , Rats, Sprague-Dawley
19.
Ann Thorac Surg ; 69(3): 847-50, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10750771

ABSTRACT

BACKGROUND: An increase of S100beta in serum during cardiopulmonary bypass (CPB) has been interpreted as a sign of brain injury. Cardiotomy suction may cause fat embolization, and its role in the S100beta increase was examined. METHODS: Twenty coronary artery operation patients were randomly assigned to two groups, 10 with suction during CPB to cardiotomy reservoir (CR), 10 to cell saving device (CS). S100beta was measured (immunoassay) in blood from the patients and from cell saving device after processing. In 7 additional patients S100beta was measured in the cell saving device before processing and directly from the wound at sternotomy. RESULTS: Before anesthesia, serum S100beta was 0.03+/-0.06 microg/L. At the end of CPB it was 2.47+/-1.31 microg/L and 0.44+/-0.27 microg/L (CR vs CS; p < 0.001). S100beta was 33+/-12 microg/L in CS reservoir and 42+/-18 microg/L in blood from the wound. CONCLUSIONS: Most serum S100beta after CPB with cardiotomy suction may be of extracerebral origin. S100beta after CPB with cell saving device was the same as after off-pump operation. The interpretation that an increase in S100beta during CPB in patients reflects cerebral injury must be questioned.


Subject(s)
Calcium-Binding Proteins/blood , Cardiopulmonary Bypass/adverse effects , Cardiopulmonary Bypass/methods , Cerebrovascular Disorders/blood , Coronary Artery Bypass/adverse effects , S100 Proteins/blood , Aged , Cerebrovascular Disorders/etiology , Humans , Middle Aged , Nerve Growth Factors , S100 Calcium Binding Protein beta Subunit , Suction
20.
Pharmacology ; 60(1): 1-8, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10629436

ABSTRACT

A subpopulation of capsaicin-sensitive cardiac C-fibre afferents co-store calcitonin gene-related peptide (CGRP), substance P and neurokinin A. CGRP exerts positive inotropic and chronotropic effects and is one of the most potent endogenous vasodilators yet discovered. A number of endogenous agents and conditions cause activation of cardiac C-fibre afferents with subsequent local release of CGRP. In myocardial ischaemia with its clinical manifestations angina pectoris and infarction, C-fibre afferents not only convey the sensation of pain, but there is also a local 'efferent' release of CGRP in the heart. After being released, CGRP causes coronary vasodilatation and attenuates the development of myocardial infarction. CGRP may thus represent an endogenous local myocardial protective substance with interesting clinical implications.


Subject(s)
Calcitonin Gene-Related Peptide/physiology , Coronary Disease/metabolism , Animals , Calcitonin Gene-Related Peptide/antagonists & inhibitors , Calcitonin Gene-Related Peptide/therapeutic use , Capsaicin/metabolism , Humans , Myocardial Reperfusion , Receptors, Calcitonin Gene-Related Peptide/metabolism , Second Messenger Systems , Tissue Distribution
SELECTION OF CITATIONS
SEARCH DETAIL
...